Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. More Details
No risks detected for MASI from our risk checks.
Flawless balance sheet with acceptable track record.
Share Price & News
How has Masimo's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MASI is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MASI's weekly volatility (4%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: MASI underperformed the US Medical Equipment industry which returned 41.4% over the past year.
Return vs Market: MASI underperformed the US Market which returned 42.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Masimo's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StInvestors Who Bought Masimo (NASDAQ:MASI) Shares Five Years Ago Are Now Up 305%
1 month ago | Simply Wall StMasimo Corporation's (NASDAQ:MASI) CEO Compensation Is Looking A Bit Stretched At The Moment
1 month ago | Simply Wall StAre Masimo Corporation (NASDAQ:MASI) Investors Paying Above The Intrinsic Value?
Is Masimo undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MASI ($239.7) is trading above our estimate of fair value ($191.99)
Significantly Below Fair Value: MASI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MASI is good value based on its PE Ratio (57.5x) compared to the US Medical Equipment industry average (58.8x).
PE vs Market: MASI is poor value based on its PE Ratio (57.5x) compared to the US market (19.2x).
Price to Earnings Growth Ratio
PEG Ratio: MASI is poor value based on its PEG Ratio (4.4x)
Price to Book Ratio
PB vs Industry: MASI is overvalued based on its PB Ratio (9.9x) compared to the US Medical Equipment industry average (4.7x).
How is Masimo forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MASI's forecast earnings growth (13% per year) is above the savings rate (2%).
Earnings vs Market: MASI's earnings (13% per year) are forecast to grow slower than the US market (15.7% per year).
High Growth Earnings: MASI's earnings are forecast to grow, but not significantly.
Revenue vs Market: MASI's revenue (7.1% per year) is forecast to grow slower than the US market (9.5% per year).
High Growth Revenue: MASI's revenue (7.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MASI's Return on Equity is forecast to be low in 3 years time (20%).
How has Masimo performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MASI has high quality earnings.
Growing Profit Margin: MASI's current net profit margins (19.5%) are lower than last year (21.6%).
Past Earnings Growth Analysis
Earnings Trend: MASI's earnings have grown by 3.5% per year over the past 5 years.
Accelerating Growth: MASI's earnings growth over the past year (8.1%) exceeds its 5-year average (3.5% per year).
Earnings vs Industry: MASI earnings growth over the past year (8.1%) underperformed the Medical Equipment industry 11.1%.
Return on Equity
High ROE: MASI's Return on Equity (17.3%) is considered low.
How is Masimo's financial position?
Financial Position Analysis
Short Term Liabilities: MASI's short term assets ($983.1M) exceed its short term liabilities ($196.9M).
Long Term Liabilities: MASI's short term assets ($983.1M) exceed its long term liabilities ($72.8M).
Debt to Equity History and Analysis
Debt Level: MASI is debt free.
Reducing Debt: MASI has no debt compared to 5 years ago when its debt to equity ratio was 83.4%.
Debt Coverage: MASI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MASI has no debt, therefore coverage of interest payments is not a concern.
What is Masimo current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MASI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MASI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MASI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MASI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MASI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Joe Kiani (55 yo)
Mr. Joseph E. Kiani, also known as Joe, founded Masimo Corporation in 1989 and has been its Chairman and Chief Executive Officer since 1989. Mr. Kiani serves as the Chairman and Chief Executive Officer of ...
CEO Compensation Analysis
Compensation vs Market: Joe's total compensation ($USD15.49M) is above average for companies of similar size in the US market ($USD11.28M).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
Experienced Management: MASI's management team is seasoned and experienced (8.2 years average tenure).
Experienced Board: MASI's board of directors are considered experienced (5.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Masimo Corporation's company bio, employee growth, exchange listings and data sources
- Name: Masimo Corporation
- Ticker: MASI
- Exchange: NasdaqGS
- Founded: 1989
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$13.184b
- Shares outstanding: 55.00m
- Website: https://www.masimo.com
Number of Employees
- Masimo Corporation
- 52 Discovery
- United States
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse ox...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/24 03:41|
|End of Day Share Price||2021/06/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.